These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 26256482)

  • 21. p27 and BCL2 expression predicts response to chemotherapy in head and neck squamous cell carcinomas.
    Moreno-Galindo C; Hermsen M; García-Pedrero JM; Fresno MF; Suárez C; Rodrigo JP
    Oral Oncol; 2014 Feb; 50(2):128-34. PubMed ID: 24239278
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 18F-FDG PET cannot predict expression of clinically relevant histopathological biomarkers in head and neck squamous cell carcinoma: a meta-analysis.
    Surov A; Pech M; Eckert A; Arens C; Grosser O; Wienke A
    Acta Radiol; 2022 Feb; 63(2):166-175. PubMed ID: 33541089
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diagnostic performance of
    Chaput A; Robin P; Podeur F; Ollivier M; Keromnes N; Tissot V; Nonent M; Salaün PY; Rousset J; Abgral R
    Laryngoscope; 2018 Feb; 128(2):378-385. PubMed ID: 28600822
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diagnostic and prognostic value of 18F-FDG PET, CT, and MRI in perineural spread of head and neck malignancies.
    Dercle L; Hartl D; Rozenblum-Beddok L; Mokrane FZ; Seban RD; Yeh R; Bidault F; Ammari S
    Eur Radiol; 2018 Apr; 28(4):1761-1770. PubMed ID: 29086023
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preoperative Contrast-Enhanced CT Versus ¹⁸F-FDG PET/CT Evaluation and the Prognostic Value of Extranodal Extension for Surgical Patients with Head and Neck Squamous Cell Carcinoma.
    Lee JR; Choi YJ; Roh JL; Kim JS; Lee JH; Cho KJ; Choi SH; Nam SY; Kim SY
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1020-7. PubMed ID: 26122372
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical significance of FDG single-photon emission computed tomography: Computed tomography in the diagnosis of head and neck cancers and study of its mechanism.
    Li LF; Zhou SH; Zhao K; Wang SQ; Wu QL; Fan J; Cheng KJ; Ling L
    Cancer Biother Radiopharm; 2008 Dec; 23(6):701-14. PubMed ID: 19317609
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prospective evaluation of pretreatment and intratreatment FDG PET-CT SUV stability in primary head and neck cancer.
    Mendez LC; Conrad T; Lee J; Smith B; Brotherston D; Le T; Kiss A; Caldwell CB; Karam I; Poon I
    Head Neck; 2019 Jun; 41(6):1889-1894. PubMed ID: 30688385
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The nodal standard uptake value (SUV) as a prognostic factor in head and neck squamous cell cancer.
    Demirci U; Coskun U; Akdemir UO; Benekli M; Kapucu O; Ozkan S; Cakir T; Baykara M; Buyukberber S
    Asian Pac J Cancer Prev; 2011; 12(7):1817-20. PubMed ID: 22126572
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reproducibility of (18)F-FDG PET uptake measurements in head and neck squamous cell carcinoma on both PET/CT and PET/MR.
    Rasmussen JH; Fischer BM; Aznar MC; Hansen AE; Vogelius IR; Löfgren J; Andersen FL; Loft A; Kjaer A; Højgaard L; Specht L
    Br J Radiol; 2015 Apr; 88(1048):20140655. PubMed ID: 25634069
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Early response monitoring with 18F-FDG PET and cetuximab-F(ab')2-SPECT after radiotherapy of human head and neck squamous cell carcinomas in a mouse model.
    van Dijk LK; Boerman OC; Franssen GM; Lok J; Kaanders JH; Bussink J
    J Nucl Med; 2014 Oct; 55(10):1665-70. PubMed ID: 25236350
    [TBL] [Abstract][Full Text] [Related]  

  • 31. FDG PET/CT and diffusion-weighted imaging of head and neck squamous cell carcinoma: comparison of prognostic significance between primary tumor standardized uptake value and apparent diffusion coefficient.
    Nakajo M; Nakajo M; Kajiya Y; Tani A; Kamiyama T; Yonekura R; Fukukura Y; Matsuzaki T; Nishimoto K; Nomoto M; Koriyama C
    Clin Nucl Med; 2012 May; 37(5):475-80. PubMed ID: 22475897
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interaction of quantitative (18)F-FDG-PET-CT imaging parameters and human papillomavirus status in oropharyngeal squamous cell carcinoma.
    Schouten CS; Hakim S; Boellaard R; Bloemena E; Doornaert PA; Witte BI; Braakhuis BJ; Brakenhoff RH; Leemans CR; Hoekstra OS; de Bree R
    Head Neck; 2016 Apr; 38(4):529-35. PubMed ID: 25352335
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Simultaneous (18)F-FDG-PET/MRI: Associations between diffusion, glucose metabolism and histopathological parameters in patients with head and neck squamous cell carcinoma.
    Surov A; Stumpp P; Meyer HJ; Gawlitza M; Höhn AK; Boehm A; Sabri O; Kahn T; Purz S
    Oral Oncol; 2016 Jul; 58():14-20. PubMed ID: 27311397
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tumor to cervical spinal cord standardized uptake ratio (SUR) improves the reproducibility of
    van den Bosch S; Dijkema T; Philippens MEP; Terhaard CHJ; Hoebers FJP; Kaanders JHAM; Oyen WJG
    Radiother Oncol; 2019 Jan; 130():39-45. PubMed ID: 30005954
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Combining standardized uptake value of FDG-PET and apparent diffusion coefficient of DW-MRI improves risk stratification in head and neck squamous cell carcinoma.
    Preda L; Conte G; Bonello L; Giannitto C; Travaini LL; Raimondi S; Summers PE; Mohssen A; Alterio D; Cossu Rocca M; Grana C; Ruju F; Bellomi M
    Eur Radiol; 2016 Dec; 26(12):4432-4441. PubMed ID: 26965504
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 18F fluorodeoxyglucose PET/CT in head and neck squamous cell carcinoma with negative neck palpation findings: a prospective study.
    Roh JL; Park JP; Kim JS; Lee JH; Cho KJ; Choi SH; Nam SY; Kim SY
    Radiology; 2014 Apr; 271(1):153-61. PubMed ID: 24475791
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Preliminary assessment of dynamic contrast-enhanced CT implementation in pretreatment FDG-PET/CT for outcome prediction in head and neck tumors.
    Abramyuk A; Wolf G; Shakirin G; Haberland U; Tokalov S; Koch A; Appold S; Zöphel K; Abolmaali N
    Acta Radiol; 2010 Sep; 51(7):793-9. PubMed ID: 20583948
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of Glut-1 in primary and recurrent head and neck squamous cell carcinomas, and compared with 2-[18F]fluoro-2-deoxy-D-glucose accumulation in positron emission tomography.
    Li SJ; Guo W; Ren GX; Huang G; Chen T; Song SL
    Br J Oral Maxillofac Surg; 2008 Apr; 46(3):180-186. PubMed ID: 18093707
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Imaging of tumour hypoxia and metabolism in patients with head and neck squamous cell carcinoma.
    Zegers CM; van Elmpt W; Hoebers FJ; Troost EG; Öllers MC; Mottaghy FM; Lambin P
    Acta Oncol; 2015; 54(9):1378-84. PubMed ID: 26213313
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunohistochemical and molecular imaging biomarker signature for the prediction of failure site after chemoradiation for head and neck squamous cell carcinoma.
    Rasmussen GB; Håkansson KE; Vogelius IR; Rasmussen JH; Friborg JT; Fischer BM; Schumaker L; Cullen K; Therkildsen MH; Bentzen SM; Specht L
    Acta Oncol; 2017 Nov; 56(11):1562-1570. PubMed ID: 28840766
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.